Shreyasi Nath

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Differential Proteomic Profiling of Responders and Non-responders to Direct-Acting Antivirals Treatment in Chronic Hepatitis C Virus Infection
  Journal of Proteome Research 2026 DOI: 10.1021/acs.jproteome.5c01003
  +Save
• Prediction of potential NS3-based T cell epitopes of hepatitis C virus by in-silico and in-vitro approach
  Scientific Reports 2026 DOI: 10.1038/s41598-026-49711-9
  +Save
• Assessment of direct-acting antiviral treatment outcomes in patients with chronic hepatitis C infected with various HCV genotypes: Insights from a real-world cohort in West Bengal, India
  BMC Infectious Diseases 2025 DOI: 10.1186/s12879-025-11565-3
  +Save
• Emergence of HCV genotype 6 and its new variants among intravenous drug users in Manipur, a north-eastern state of India
  Therapeutic Advances in Infectious Disease 2025 DOI: 10.1177/20499361251351302
  +Save
• Impact of hepatitis C virus genotype on the efficacy of the direct-acting antivirals in chronic kidney disease patients in West Bengal, India
  BMC Infectious Diseases 2025 DOI: 10.1186/s12879-025-10947-x
  +Save
• Efficacy of Different Combinations of Direct-Acting Antivirals Against Different Hepatitis C Virus-Infected Population Groups: An Experience in Tertiary Care Hospitals in West Bengal, India
  Viruses 2025 DOI: 10.3390/v17020269
  +Save
• Molecular Epidemiology of HCV Infection among Multi-Transfused β-Thalassemia Patients in Eastern India: A Six-Year Observation
  Thalassemia Reports 2023 DOI: 10.3390/thalassrep13030016
  +Save
• Molecular Epidemiology of Hepatitis C Virus Infection and Evaluation of the Outcome of Direct Acting Antivirals Treatment in Patients with Chronic Liver Disease in West Bengal, India
  Journal of Clinical and Experimental Hepatology 2023 DOI: 10.1016/j.jceh.2023.07.040
  +Save